Breast ReconstructionNCT06629012
Autologous Nerve Graft Breast Reconstruction Neurotization
An observational study of Breast Reconstruction and Breast Cancer Patients, run by Chang Gung Memorial Hospital at 1 site in Taiwan.
Trial summary
The goal of this observational study is to learn about the improvement of quality of life in accordance with breast neurotization in breast cancer patients. The patient-reported outcome was assessed by questionnaire. Read more about this study
- Who is it for?
- Ages 20 years and older, women only
- Conditions the study is for
- Breast Reconstruction, Breast Cancer Patients, Nipple-sparing Mastectomy
- What is being tested?
- Breast reconstruction with neurotization and Breast reconstruction without neurotization
- Type of treatment
- Surgery or procedure
- How many people
- 250 participants
- Where
- 1 siteTaiwan
- Study dates
- 29 Nov 2021to 31 Dec 2026
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Study population: Patients undergoing nipple-sparing mastectomy and immediate breast reconstruction
Who may be able to join
- Patient who receive breast reconstruction
- Patient who is willing to fill in the questionnaire
Who cannot join
- Patient who receive breast reconstruction for the reason other than breast cancer
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Breast Neurotization During Breast Reconstruction Enhances Quality of Life
The goal of this observational study is to learn about the improvement of quality of life in accordance with breast neurotization in breast cancer patients. The patient-reported outcome was assessed by questionnaire.
- Being tested
- Breast reconstruction with neurotization, Breast reconstruction without neurotization
- Keywords
- breast reconstruction, nipple-sparing mastectomy, breast neurotization, quality of life, autologous nerve graft, nipple sensation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Breast reconstruction with neurotizationProcedure or surgery
Patients received breast reconstruction with neurotization procedure
Breast reconstruction without neurotizationProcedure or surgery
Patients received breast reconstruction without neurotization
| Study group | Role | What they receive |
|---|---|---|
| Innervated group | Patients received breast neurotization Receives: Procedure: Breast reconstruction with neurotization | |
| Non-innervated group | Patients did not receive breast neurotization Receives: Procedure: Breast reconstruction without neurotization |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pre-operative Quality of life
Patient-reported outcome assessed by the BREAST-Q™ Reconstruction module questionnaire and a additional questionnaire regarding sensation, nipple satisfaction, and breast symptoms
Measured: Before breast reconstructive surgery
Post-operative-two-year Quality of life
Patient-reported outcome assessed by the BREAST-Q™ Reconstruction module questionnaire and a additional questionnaire regarding sensation, nipple satisfaction, and breast symptoms
Measured: Two-year after breast reconstructive surgery
Post-operative-one-year Quality of life
Patient-reported outcome assessed by the BREAST-Q™ Reconstruction module questionnaire and a additional questionnaire regarding sensation, nipple satisfaction, and breast symptoms
Measured: One-year after breast reconstructive surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2024
- Study start29 Nov 2021
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast ReconstructionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 250 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chang Gung Memorial Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jung-Ju Huang, Chang Gung Memorial Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06629012
- Sponsor's protocol ID
- 202101923B0-N
- Status last verified
- Oct 2026
- First submitted
- 3 Oct 2024
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Patient privacy